腹主动脉瘤直径对EVAR术后中远期死亡率的影响
单中心回顾性队列纳入2003至2013年325例连续接受EVAR的完整腹主动脉瘤患者,按ROC确定的5.6 cm切点分组,比较3、5、10年全因死亡。结果显示AAA≥5.6 cm与3年死亡风险升高相关(HR 1.59),但校正合并症后不再显著;远期AAA直径并非死亡的独立预测因素。
要点
- AAA直径≥5.6 cm与EVAR术后3年全因死亡风险升高相关。
- 校正年龄及合并症后,AAA直径与各时点死亡率均无显著独立关联。
- 术前AAA直径不是EVAR术后远期死亡的独立预测因素。
核心结论
- AAA直径≥5.6 cm与EVAR术后3年死亡风险升高相关,但校正合并症后不再显著。
- 远期随访中术前AAA直径并非死亡的独立预测因素。
研究设计与样本
- 采用ROC曲线确定AAA直径与年龄的最佳切点,以Kaplan-Meier曲线和Cox比例风险模型分析全因死亡。
主要发现
- ROC分析确定AAA直径最佳切点为5.6 cm,年龄切点为>70岁。
- 平均随访45.5±29.2个月,10年随访期间共134例(41.2%)死亡。
- AAA≥5.6 cm与3年死亡风险升高相关(HR 1.59,95%CI 1.001–2.52,p<0.049),5年(HR 1.44,95%CI 0.98–2.10,p=0.062)和10年(HR 1.28,95%CI 0.91–1.80,p=0.149)无显著关联。
- 校正合并症后AAA≥5.6 cm与各时点死亡率均无显著关联;未校正模型中AAA≥6.0 cm的3年死亡风险显著升高(HR 1.67,95%CI 1.01–2.77,p<0.047),更长时点不显著。
临床怎么用
- EVAR术前应综合评估AAA直径与合并症,直径≥5.6 cm者中期死亡风险较高,需加强术后随访管理。
- 不应仅凭术前AAA直径预测EVAR术后远期死亡风险。
局限性
- 单中心回顾性研究,样本量有限,结论外推需谨慎。
- 校正合并症后AAA直径与死亡率的关联不再显著,提示结果可能受混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the effect of abdominal aortic aneurysm (AAA) size on mid- and long-term survival after endovascular aneurysm repair (EVAR). MATERIALS AND METHODS: Retrospective data were collected from 325 consecutive patients (mean age 69.7 ± 8.5 years; 323 men) who underwent EVAR for intact AAA at a single institution between January 2003 and December 2013. The primary endpoint was death at 3, 5, and 10 years after EVAR. Optimal cutoff points for AAA size and age were determined using receiver operating characteristics (ROC) curves. Time to event analyses (Kaplan-Meier curves and Cox proportional hazard models) were employed to determine any differences in all-cause mortality outcomes between AAA size groups. Cox models were adjusted for age and other comorbidities (hypertension, hyperlipidemia, coronary artery disease, smoking status, symptomatic status, and creatinine); the outcomes are reported as the hazard ratio (HR) with 95% confidence interval (CI). RESULTS: The cohort was dichotomized according to the ROC analysis, which defined an optimal cutoff point of 5.6 cm for AAA size and >70 years for age. The mean follow-up period post EVAR was 45.5±29.2 months. In total, 134 (41.2%) patients died during the 10-year follow-up. Thirty-day mortality was 1.1% (2/184) in the patients with AAA <5.6 cm and 2.1% (3/141) in patients with AAA ≥5.6 cm (p=0.45). All-cause mortality was not significantly affected by comorbidities. However, AAA size ≥5.6 cm was associated with increased 3-year mortality risk (HR 1.59, 95% CI 1.001 to 2.52, p<0.049) but not 5-year (HR 1.44, 95% CI 0.98 to 2.10, p=0.062) or 10-year mortality (HR 1.28, 95% CI 0.91 to 1.80, p=0.149). After adjusting for comorbidities, AAA size ≥5.6 cm was no longer significantly associated with morality at any time point. Using a larger size cutoff (AAA size ≥6.0 cm) resulted in improved statistical significance in the unadjusted model. In the adjusted Cox model, AAA size ≥6.0 cm was significantly associated with increased risk of mortality at 3 years (HR 1.67, 95% CI 1.01 to 2.77, p<0.047), but not at longer time points. CONCLUSION: Our study demonstrates that midterm survival after EVAR is significantly and independently associated with AAA size even after correcting for comorbidities. However, in the long term, preoperative AAA size is not an independent predictor of mortality.
引用
- Jeon-Slaughter H, Krishnamoorthi H, Timaran D, et al. Effects of Abdominal Aortic Aneurysm Size on Mid- and Long-term Mortality After Endovascular Aneurysm Repair. J Endovasc Ther. 2019. PMID: 30741076. doi:10.1177/1526602819829901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。